Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,985 | 140 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $874.16 | 60 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $588.16 | 14 | $0 (2024) |
| Axsome Therapeutics, Inc. | $370.27 | 16 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $298.28 | 5 | $0 (2024) |
| Lundbeck LLC | $137.04 | 9 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $135.04 | 7 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $117.53 | 1 | $0 (2021) |
| Alkermes, Inc. | $71.23 | 5 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $58.56 | 4 | $0 (2024) |
| Pulmonx Corporation | $46.32 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $930.66 | 34 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($298.28) |
| 2023 | $932.76 | 44 | Axsome Therapeutics, Inc. ($322.12) |
| 2022 | $535.76 | 24 | Otsuka America Pharmaceutical, Inc. ($233.74) |
| 2021 | $585.74 | 38 | AbbVie Inc. ($244.98) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $33.40 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/15/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $126.62 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $111.44 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 321 | 1,517 | $270,939 | $115,751 |
| 2022 | 12 | 352 | 1,303 | $194,480 | $97,102 |
| 2021 | 11 | 314 | 983 | $148,725 | $78,812 |
| 2020 | 6 | 169 | 281 | $34,065 | $17,340 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 532 | $108,464 | $46,962 | 43.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 65 | 441 | $88,095 | $27,243 | 30.9% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 36 | 272 | $38,900 | $24,223 | 62.3% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 28 | 180 | $16,740 | $9,294 | 55.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $11,135 | $2,931 | 26.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $4,125 | $2,633 | 63.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,000 | $1,571 | 78.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 11 | $1,375 | $790.18 | 57.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 21 | $105.00 | $102.90 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 447 | $78,410 | $39,364 | 50.2% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 25 | 301 | $33,110 | $20,876 | 63.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 46 | 289 | $50,575 | $18,060 | 35.7% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 16 | 62 | $8,360 | $5,058 | 60.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 20 | 74 | $7,400 | $4,589 | 62.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 18 | 19 | $3,975 | $2,643 | 66.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,315 | $2,296 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $2,300 | $1,887 | 82.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $910.00 | $891.02 | 97.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $1,365 | $767.66 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $595.00 | $573.42 | 96.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 33 | $165.00 | $97.89 | 59.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 336 | $56,690 | $30,591 | 54.0% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 16 | 167 | $18,370 | $11,991 | 65.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 34 | 180 | $31,500 | $11,842 | 37.6% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2021 | 20 | 91 | $12,005 | $7,810 | 65.1% |
About Sandra Winters, CRNP
Sandra Winters, CRNP is a Family healthcare provider based in Scranton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174613475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Winters, CRNP has received a total of $2,985 in payments from pharmaceutical and medical device companies, with $930.66 received in 2024. These payments were reported across 140 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,985).
As a Medicare-enrolled provider, Winters has provided services to 1,156 Medicare beneficiaries, totaling 4,084 services with total Medicare billing of $309,005. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Scranton, PA
- Active Since 10/15/2006
- Last Updated 02/03/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1174613475
Products in Payments
- VRAYLAR (Drug) $804.39
- REXULTI (Drug) $446.69
- CAPLYTA (Drug) $324.57
- Auvelity (Drug) $221.61
- Sunosi (Drug) $148.66
- LATUDA (Drug) $135.04
- NUEDEXTA (Drug) $126.00
- INGREZZA (Drug) $117.53
- ABILIFY MAINTENA (Drug) $95.99
- LYBALVI (Drug) $57.62
- ABILIFY ASIMTUFII (Drug) $56.52
- CHARTIS CATHETER (Device) $46.32
- Nuedexta (Drug) $42.82
- Qelbree (Drug) $42.39
- UBRELVY (Drug) $39.27
- HETLIOZ (Drug) $37.79
- COBENFY (Drug) $33.40
- Austedo XR (Drug) $32.56
- SUNOSI (Drug) $29.86
- TRINTELLIX (Drug) $28.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Scranton
Karen Zikosky, Crnp, CRNP
Family — Payments: $30,598
Theresa Germano
Family — Payments: $7,676
Tracy Sokoloski, Crnp, CRNP
Family — Payments: $3,143
Olivia Julian, Crnp, CRNP
Family — Payments: $2,076
Mrs. Stefani Vanston, Crnp, CRNP
Family — Payments: $1,893
Jessica Redding, Np, NP
Family — Payments: $1,487